Celemics, Inc. (KOSDAQ:331920)

Market Cap	104.91B +311.9%
Revenue (ttm)	5.77B -14.2%
Net Income	-4.04B
EPS	-494.00
Shares Out	8.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,897
Average Volume	564,862
Open	13,150
Previous Close	12,850
Day's Range	12,450 - 13,180
52-Week Range	2,535 - 13,990
Beta	-0.58
RSI	83.51
Earnings Date	Apr 3, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Employees: 40
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920